Share on LinkedInShare on LinkedIn

ARTICLE · 18 NOVEMBER 2010

Baxter Breaches of the Trade Practices Act bring $4.9m penalty

On 26 August 2010, the Full Federal Court handed down penalties of $4.9 million against Baxter Healthcare Pty Ltd (Baxter) for breaches of sections 46 and 47 of the Trade Practices Act 1974 (Act).

AustraliaConsumer Protection
Richard Owens
Richard Owens

On 26 August 2010, the Full Federal Court handed down penalties of $4.9 million against Baxter Healthcare Pty Ltd (Baxter) for breaches of sections 46 and 47 of the Trade Practices Act 1974 (Act).1

The penalty decision follows the 2008 Full Court decision that Baxter breached sections 46 and 47 of the Act by bundling its sterile fluids (SF) product with its peritoneal dialysis fluids (PD) product.2 Section 46 of the Act prohibits taking advantage of market power. Section 47 prohibits exclusive dealing.

In terms of section 46, Baxter had substantial market power in its SF product but faced competition in its PD product. Baxter offered to supply four States (NSW, Queensland, South Australia and Western Australia) its SF and PD products bundled together at a substantial discount to the price at which it offered to supply the products separately. The bundling was done for the purpose of deterring or preventing others from competing in the PD market.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from